Heptares, Kymab to develop novel antibody therapeutics in 'perfect marriage,' says CFO
Heptares Therapeutics and Kymab Limited have entered into a strategic collaboration to discover, develop, and commercialize novel antibody therapeutics.
Archives for April 18, 2016
Alembic Indian plant hit with US FDA Form 483 and four observations
The US FDA has hit an Indian formulation facility run by Alembic Pharmaceuticals with a Form 483 with four observations.
Johnson Matthey and Domainex team on API discovery and development
Johnson Matthey has teamed up with Domainex to offer integrated API discovery, preclinical development and manufacturing services.
Pace of change in CRO industry increasing, says ISR
More funding from capital investments and higher outsourcing levels are increasing the pace of change in the CRO industry, says ISR president.
Continuous or not? Janssen cites inventory benefits of new Prezista process
Janssen says the new US FDA-approved production method for its HIV drug Prezista is more efficient and will help it better control inventory.
Evotec has been contracted to manage candidate APIs by Pierre Fabre
Evotec has been hired to manage candidate drug compounds by French privately-owned pharmaceutical firm Pierre Fabre.